Brian J. Hayden files SEC Form 4 disclosures for SAVIENT PHARMACEUTICALS INC. They have made 6 open-market trades across 1 company since 2007, most recently 2009-02-17.
CIK 0001262224
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SVNT | 11,445 | — |
Shares reported on the most recent Form 4, priced at the 2009-02-19 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SVNT | SELL · 10b5-1 | 2009-02-17 | 2009-02-19 | $5.77 | $20K | N/A | N/A | N/A |
| SVNT | SELL | 2008-05-06 | 2008-05-08 | $24.00 | $120K | N/A | N/A | N/A |
| SVNT | SELL | 2008-05-02 | 2008-05-06 | $24.00 | $120K | N/A | N/A | N/A |
| SVNT | SELL | 2008-02-28 | 2008-03-03 | $24.04 | $175K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2008-02-15 | 2008-02-20 | $19.98 | $56K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-02 | 2008-01-04 | $23.87 | $239K | N/A | N/A | N/A |
| SVNT | SELL | 2007-12-18 | 2007-12-19 | $20.09 | $100K | N/A | N/A | N/A |
| SVNT | SELL | 2007-12-13 | 2007-12-17 | $18.07 | $271K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2007-03-05 | 2007-03-07 | $12.52 | $56K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.